Untitled

Abstract

Epworth sleepiness scale (ESS) is widely used to evaluate degree of somnolence among Chinese patients with sleep-disordered breathing. Yet no Mandarin-Chinese translation has ever reported its validation data. In this study we translated and validated the ESS into Mandarin Chinese (CESS). We found, in 31 bilingual patients' responses to the CESS and the English ESS obtained 1-2 weeks apart did not differ significantly (10.5 +/- 3.7 vs. 9.6 +/- 3.9, p = 0.32, Wilcoxon's signed rank test) and were significantly correlated (Spearman's p = 0.67, p = 0.0004). A total of 359 sleep-disordered breathing subjects were enrolled into the validation study in a prospective manner. The CESS showed acceptable internal consistency (Cronbach's alpha = 0.81). Thirty out of these patients answered CESS twice at an interval of 2-4 weeks, to yield an acceptable level of test-retest reliability (p = 0.74, p = 0.001). The respiratory disturbance indices obtained from 251 out of 359 subjects were significantly correlated with their CESS scores (p = 0.22, p < 0.001). The standard response mean of CESS was 0.86 as obtained from 94 out of 359 subjects who had initial control of their symptoms at 3 months after radio-frequency palate surgery. We conclude that the CESS is reliable in both a linguistic and a test-retest sense, and appears to be valid and sensitive to clinical change. The CESS could be used to advantage among other Mandarin-speaking subjects as a standardised screening test of sleepiness in daily life.

Sleep Disorders and Sleep Quality in Moroccan Adult Patients with Cancer during Treatment

“…Unlike the previous reports in literature [9,13], this work found that patients with head and neck cancer and urologic cancer had the highest insomnia prevalence, surprisingly breast and gynecological cancer had lowest prevalence of insomnia. Regarding treatment type, we found in this study that clinical insomnia was the most associated with chemotherapy (62%), this result agrees with the findings of the literature [9,22]. Berger and Fair reported that women undergoing chemotherapy for breast cancer who had more objectively measured daytime sleep and nighttime awakenings reported more chemotherapyrelated fatigue [23].…”

Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients

“…The proposed range for normal sleep propensity is 0–10. The Chinese version of Epworth sleepiness scale also appears to have good internal consistency and reliability among Mandarin-speaking subjects as a standardized screening test of sleepiness in daily life, with the same cut-off value [20]. The PSQI is a self-report questionnaire that assesses sleep quality over a 1-month time period.…”

Sleep disturbances in Taiwanese patients with Parkinson's disease

“…The severity of PD was evaluated using the UPDRS and the Hoehn and Yahr stage (H&Y stage), and both scores were determined without stopping medication. Nighttime and daytime sleep problems were evaluated using the Pittsburgh Sleep Quality Index (PSQI) (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) and the Epworth Sleepiness Scale (ESS), respectively (Chen et al., 2002; Johns, 1991). We evaluated the sleep problems that might be relevant to PD symptoms by using the Parkinson's Disease Sleep Scale (PDSS) (Chaudhuri et al., 2002), and the quality of life of PD patients was assessed using the 39‐Item Parkinson's Disease Questionnaire (PDQ‐39) (Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman, 1997).…”

“…Following the generally accepted criteria, we use PSQI > 5 to identify PD patients as poor sleepers (Buysse et al., 1989) and ESS ≥ 10 to identify those with daytime sleep disorders (EDS) (Chen et al., 2002; Johns, 1991). …”